Rand J H, Wu X X, Potter B J, Uson R R, Gordon R E
Department of Medicine, Mount Sinai School of Medicine, New York, NY 10029.
Am J Pathol. 1993 Mar;142(3):843-50.
The binding of von Willebrand factor (vWF) to subendothelium constitutes an important initial step in the process of platelet adhesion to exposed subendothelium following blood vessel injury. We previously demonstrated that vWF is present in human vascular subendothelium and recently found that a 150 kd vWF-binding protein, which we extracted from subendothelium, is type VI collagen. Although we have established that vWF and type VI collagen bind in vitro, it is not known whether these two proteins are associated in the vascular subendothelium in situ. We, therefore, 1) investigated the morphological effects of our biochemical extraction procedure on human umbilical veins by scanning and transmission electron microscopy, 2) analyzed the subendothelial extract by immunofluorescence for the presence of vWF and collagens and by electron microscopy for morphological characteristics, and 3) localized vWF and type VI collagen in subendothelium by immunofluorescence and by single- and double-label immunoelectron microscopic studies with protein A-conjugated gold particles. We found that the surface exposed following de-endothelialization is composed of microfibrils and contains very little fibrillar collagen. The subendothelium is stripped after sodium dodecyl sulfate-urea extraction, and the extract itself contains immunoreactive vWF and type VI collagen but no immunoreactive type I or III fibrillar collagens. Immunofluorescence and immunoelectron microscopic studies showed that vWF and type VI collagen are both present in subendothelium, where both co-localized to microfibrils. In conclusion, vWF that binds to type VI collagen in vitro, also co-localizes with type VI collagen in subendothelium, where both are associated with microfibrils. Type VI collagen, therefore appears to serve as a biologically significant binding site for vWF in vivo and may thereby play a role in mediating platelet adhesion to exposed subendothelium following vascular injury.
血管性血友病因子(vWF)与内皮下组织的结合是血管损伤后血小板黏附于暴露的内皮下组织过程中的一个重要起始步骤。我们先前证明vWF存在于人类血管内皮下组织中,并且最近发现我们从内皮下组织中提取的一种150 kd的vWF结合蛋白是VI型胶原。尽管我们已经确定vWF和VI型胶原在体外能够结合,但尚不清楚这两种蛋白在原位血管内皮下组织中是否相关联。因此,我们:1)通过扫描电子显微镜和透射电子显微镜研究了我们的生化提取程序对人脐静脉的形态学影响;2)通过免疫荧光分析内皮下提取物中vWF和胶原的存在情况,并通过电子显微镜观察其形态特征;3)通过免疫荧光以及使用蛋白A偶联金颗粒的单标记和双标记免疫电子显微镜研究,在血管内皮下组织中定位vWF和VI型胶原。我们发现去内皮后暴露的表面由微原纤维组成,并且含有极少的纤维状胶原。十二烷基硫酸钠 - 尿素提取后内皮下组织被剥离,提取物本身含有免疫反应性vWF和VI型胶原,但不含免疫反应性I型或III型纤维状胶原。免疫荧光和免疫电子显微镜研究表明,vWF和VI型胶原均存在于内皮下组织中,二者都共定位于微原纤维。总之,在体外与VI型胶原结合的vWF,在内皮下组织中也与VI型胶原共定位,二者都与微原纤维相关联。因此,VI型胶原似乎在体内作为vWF的一个具有生物学意义的结合位点,并且可能在介导血管损伤后血小板黏附于暴露的内皮下组织中发挥作用。